2349
We report a 71-year male with castration-resistant metastatic prostate cancer who was treated with weekly docetaxel for 12 weeks and developed significant eye irritation and dryness during treatment.
 ( adverse event: developed ,  a 71-year male with castration-resistant metastatic prostate cancer: Subject, 71-year: Subject.Age, male: Subject.Gender, significant eye irritation and dryness: Effect, weekly docetaxel for 12 weeks: Treatment, castration-resistant metastatic prostate cancer: Treatment.Disorder, docetaxel: Treatment.Drug, weekly: Treatment.Freq, 12 weeks: Treatment.Duration) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: adverse event,potential therapeutic event, Arguments type: Treatment.Disorder,Treatment.Time_elapsed,Treatment.Dosage,Subject.Race,Treatment.Drug,Treatment.Route,Subject.Disorder,Treatment.Freq,Treatment,Effect,Subject.Population,Treatment.Duration,Combination.Drug,Subject,Subject.Age,Subject.Gender. 
Text: {0} 
Answer:
 ( adverse event: developed ,  a 71-year male with castration-resistant metastatic prostate cancer: Subject, 71-year: Subject.Age, male: Subject.Gender, significant eye irritation and dryness: Effect, weekly docetaxel for 12 weeks: Treatment, castration-resistant metastatic prostate cancer: Treatment.Disorder, docetaxel: Treatment.Drug, weekly: Treatment.Freq, 12 weeks: Treatment.Duration) 